Biotech Investor Adds Million as Krystal Biotech Revenue Rises
A major biotech investor is stepping up its bet on Krystal Biotech as the company posts robust 2025 revenue. This mov...
Explore zero based budgeting practices among families, focusing on habits that sustain discipline, transparency, and ongoing adjustment.
21,440 articlesA major biotech investor is stepping up its bet on Krystal Biotech as the company posts robust 2025 revenue. This mov...
Eos Energy Enterprises missed revenue expectations for Q4 2025, sparking a 39% one-day drop and renewed debate about ...
A high-profile insider sale at Urban Outfitters has investors weighing risk and opportunity. Learn how to interpret t...
DocuSign's 2026 earnings narrative centers on ARR expansion, margin discipline, and stronger cash flow in a competiti...
A biotech insider sale can spark questions about company momentum. This article digs into the Stoke Therapeutics CMO ...
The S&P 500 surged to a new high driven by a small group of mega-cap tech giants, even as hundreds of other component...
Rigetti Computing stock rocketing headlines a broader burst of investor interest in quantum tech. Here’s what’s drivi...
A big institutional move sent ripples through MercadoLibre as NWI Management dumped a large block of shares. This art...
SpaceX stunned markets by setting a fixed IPO price of $135. Is this a bold power move or a warning sign for investor...
A hypothetical SpaceX IPO could ride a powerful tailwind if a Google cloud deal brings $30 billion in AI compute reve...
An insider move of 8,000 shares can raise questions for investors. This article breaks down what such a sale might si...
When volatility rattles the market, smart investors look for steady performers. Costco isn’t just a discount retailer...